ViewRay's radiation therapy system can be sold in China
Image-guided radiation therapy vendor ViewRay's MRIdian MRI-guided radiatio...Read more on AuntMinnie.comRelated Reading:
ViewRay signs VA Houston Healthcare System
ViewRay reports revenue spike for Q2
French university hospital picks ViewRay rad therapy system
FDA to allow Bayer to import contrast media
VA Ann Arbor expands use of ViewRay radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 7, 2022 Category: Radiology Source Type: news
ViewRay Announces China NMPA Approval of its MRIdian(R) MRI-Guided Radiation Therapy for Cancer Patients
This approval expands MRIdian's global reach and offers cancer patients a new radiation therapy optionMRIdian SMART
DENVER, Sept. 7, 2022 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the company's MRId... Devices, Oncology, Regulatory ViewRay, MRIdian, MRI-guided radiation therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2022 Category: Pharmaceuticals Source Type: news
IMV: Broad use of fixed C-arms in hospitals drives future demand
The widespread use of C-arms across radiology, cardiology, and surgery department...Read more on AuntMinnie.comRelated Reading:
Nuclear medicine sentiment improves with expectations for higher volume
IMV: Radiation therapy capital equipment budgets up 21% in 2021
IMV: Most U.S. hospitals plan to buy an x-ray system
IMV: MRI procedure volume fell 35% in 2020
IMV: CT procedure volume fell 20% in 2020 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 6, 2022 Category: Radiology Source Type: news
IBA reports revenue increase in first half of 2022
Proton therapy developer Ion Beam Applications (IBA) reported an increase i...Read more on AuntMinnie.comRelated Reading:
IBA to collaborate with ScandiDos
IBA signs collaboration on proton therapy
IBA forms ConformalFlash alliance
Proton online adaptive radiation therapy group formed
IBA acquires Modus Medical Devices (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 1, 2022 Category: Radiology Source Type: news
ASTRO issues guide on radiation therapy for glioma
The American Society for Radiation Oncology (ASTRO) has issued a guide on th...Read more on AuntMinnie.comRelated Reading:
ASTRO recognizes fellows class for 2022
ASTRO sees opportunity in CMS delay of RO Model
AUA, ASTRO release new prostate cancer guideline
ASTRO releases EBRT guidelines for liver cancer treatment
ASTRO 2021 studies tackle racial disparities, high costs (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 31, 2022 Category: Radiology Source Type: news
IBA to collaborate with ScandiDos
Proton therapy developer Ion Beam Applications (IBA) and Swedish radiation therap...Read more on AuntMinnie.comRelated Reading:
IBA signs collaboration on proton therapy
IBA forms ConformalFlash alliance
Proton online adaptive radiation therapy group formed
IBA acquires Modus Medical Devices
IBA to partner with Dutch hospital on breast cancer research (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 31, 2022 Category: Radiology Source Type: news
RaySearch posts mixed results in Q2
Radiation therapy software developer RaySearch Laboratories produced a 3.6...Read more on AuntMinnie.comRelated Reading:
RaySearch tech to be used in Houston clinic
RaySearch launches latest version of RayStation
Proton online adaptive radiation therapy group formed
RaySearch releases RayCare update
RaySearch, GE partner on radiation therapy planning (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 30, 2022 Category: Radiology Source Type: news
CMS: Radiation Oncology (RO) Model
Notice from the Centers for Medicare& Medicaid Services (CMS) finalizing the proposal to delay the start date of the Radiation Oncology (RO) Model and establish the start and end dates for the model through future rulemaking, which may involve modifications to the model design. The RO Model will test whether prospective episode payments to hospital outpatient departments and freestanding radiation therapy centers for radiation therapy episodes of care preserve or enhance the quality of care furnished to Medicare beneficiaries while reducing Medicare program spending. This final rule is effective October 28, 2022. (Source: ...
Source: Federal Register updates via the Rural Assistance Center - August 29, 2022 Category: Rural Health Source Type: news
Public Inspection: CMS: Radiation Oncology Model
Pre-publication notice from the Centers for Medicare& Medicaid Services (CMS) finalizing the proposal to delay the start date of the Radiation Oncology (RO) Model and establish the start and end dates for the model through future rulemaking, which may involve modifications to the model design. The RO Model will test whether prospective episode payments to hospital outpatient departments and freestanding radiation therapy centers for radiation therapy episodes of care preserve or enhance the quality of care furnished to Medicare beneficiaries while reducing Medicare program spending. This final rule is effective 60 days aft...
Source: Federal Register updates via the Rural Assistance Center - August 26, 2022 Category: Rural Health Source Type: news
CMS officially postpones changes to radiation therapy payments
The U.S. Centers for Medicare and Medicaid Services (CMS) has issued a fina...Read more on AuntMinnie.comRelated Reading:
ASTRO sees opportunity in CMS delay of RO Model
CMS again delays start of RO Model for radiation therapy payments
Congress passes bill that eases Medicare payment cuts to radiology
House passes bill to mitigate Medicare cuts
ASTRO calls proposed CMS cuts 'draconian' (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 25, 2022 Category: Radiology Source Type: news
VA Houston Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
This is the First Hospital in Texas and the Third VA Hospital to Offer MRIdian® MRI-guided Radiation Therapy Cancer Treatment.
DENVER, Aug. 23, 2022 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the ... Devices, Oncology ViewRay, MRIdian, MRI-guided radiation therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 23, 2022 Category: Pharmaceuticals Source Type: news
Gut Microbiome Tied to Radiation Therapy Outcomes in HNC Gut Microbiome Tied to Radiation Therapy Outcomes in HNC
Specific enrichments are associated with oral mucositis and recurrence after radiation therapy.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
IBA signs collaboration on proton therapy
Proton therapy developer Ion Beam Applications (IBA) has signed a collaboratio...Read more on AuntMinnie.comRelated Reading:
IBA forms ConformalFlash alliance
Varian secures IDE for new Flash clinical trial
Proton online adaptive radiation therapy group formed
B dot touts progress in proton therapy development
B dot says study shows feasibility of compact proton therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 4, 2022 Category: Radiology Source Type: news
ViewRay reports revenue spike for Q2
Image-guided radiation therapy vendor ViewRay reported a major increase in revenue...Read more on AuntMinnie.comRelated Reading:
ViewRay reports revenue increases for Q4, fiscal year
ViewRay reports major revenue boost in Q3
ViewRay posts mixed financial results for Q4, year
ViewRay's revenue plummets in Q3
ViewRay's revenue spikes in 2019, despite slow Q4 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 3, 2022 Category: Radiology Source Type: news
MARF to Host International Symposium on Malignant Mesothelioma
Leading medical specialists will gather with mesothelioma patients, families, friends and advocates at the much-anticipated 2022 International Symposium on Malignant Mesothelioma, July 23, in Chicago. This is an event well worth attending.
The day-long symposium will be held at Summit Chicago, a welcoming venue where a wide range of mesothelioma experts will be speaking on related topics and mixing with all those who attend.
This is the first in-person gathering for the annual event since 2019 because of the COVID-19 pandemic. Much of the symposium will be available for viewing virtually, free of charge, for those un...
Source: Asbestos and Mesothelioma News - July 20, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Awareness/Advocacy Mesothelioma Peritoneal Pleural Treatment Source Type: news
